Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-12-18
1989-10-03
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A01N 4380
Patent
active
048717541
ABSTRACT:
Aqueous solutions are protected from infestation by micro-organisms by use of a biocide which is an aqueous formulation of the lithium salt of 1,2-benzisothiazolin-3-one.
REFERENCES:
patent: 3065123 (1962-11-01), Hinton et al.
patent: 4150026 (1979-04-01), Miller et al.
patent: 4188376 (1980-02-01), Payne et al.
"Mycotoxine aus Schimmelpilzen", (Mycotoxines from Molds), by Burchard Franck in Angewandte Chemie (Applied Chemistry), International Edition, pp. 493-505.
Karl Heinz Wallhausser: Praxis der Sterilisation, Desinfektion-Konservierung-Keimidentifizierung-Betriebshygiene, (Practice for Sterilization Disinfection-Preservation Germ Identification-Industrial Hygiene), Georg Thieme Verlag, Stuttgart/New York, 3rd revised and enlarged edition, 1984, pp. 460 and 461.
Kirk-Othmer, Encyclopedia of Chemical Technology, 3rd ed., vol. 7, pp. 170 and 171.
Bauer Wolfgang
Steckelberg Willi
Cassella Aktiengesellschaft
Schenkman Leonard
LandOfFree
Aqueous formulation of 1,2-benzisothiazolin-3-one does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aqueous formulation of 1,2-benzisothiazolin-3-one, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous formulation of 1,2-benzisothiazolin-3-one will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-664620